Investing News

Vertex, CRISPR Therapeutics Get FDA Approval for First CRISPR Gene-Editing Therapy in US

Vertex Pharmaceuticals and CRISPR Therapeutics received regulatory approval for the first gene-editing therapy using CRISPR technology in the U.S.

Articles You May Like

3 Stock Downgrades That Analysts Are Going to Regret
Exit Now! 3 Social Media Stocks to Sell in February 2024
3 Stocks to Buy That Are Up 100% or More in 2024
Beware This Battery Stock: Why QuantumScape’s Latest Moves Demand Investor Caution
The Best 7 Tech Stocks to Buy for AI Cloud Exposure